pith. sign in

arxiv: 2602.13430 · v2 · pith:YTGOHG5Snew · submitted 2026-02-13 · 💻 cs.CV

Handling Supervision Scarcity in Chest X-ray Classification: Long-Tailed and Zero-Shot Learning

classification 💻 cs.CV
keywords classesclassificationlong-tailedmulti-labelsupervisionzero-shotchestdisease
0
0 comments X
read the original abstract

Chest X-Ray (CXR) classification in clinical practice is often limited by imperfect supervision, arising from (i) extreme long-tailed multi-label disease distributions and (ii) missing annotations for rare or previously unseen findings. The CXR-LT 2026 challenge addresses these issues on a PadChest-based benchmark with a 36-class label space split into 30 in-distribution classes for training and 6 out-of-distribution (OOD) classes for zero-shot evaluation. We present task-specific solutions tailored to the distinct supervision regimes. For Task 1 (long-tailed multi-label classification), we adopt an imbalance-aware multi-label learning strategy to improve recognition of tail classes while maintaining stable performance on frequent findings. For Task 2 (zero-shot OOD recognition), we propose a prediction approach that produces scores for unseen disease categories without using any supervised labels or examples from the OOD classes during training. Evaluated with macro-averaged mean Average Precision (mAP), our method achieves strong performance on both tasks, ranking first on the public leaderboard of the development phase. Code and pre-trained models are available at https://github.com/hieuphamha19/CXR_LT.

This paper has not been read by Pith yet.

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Forward citations

Cited by 1 Pith paper

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score.

  1. CXR-LT 2026 Challenge: Multi-Center Long-Tailed and Zero Shot Chest X-ray Classification

    cs.CV 2026-04 accept novelty 6.0

    CXR-LT 2026 introduces a radiologist-annotated multi-center dataset of 145k+ CXRs to benchmark robust multi-label classification on known classes and open-world generalization to unseen rare diseases.